Syria’s medical sector at a crossroads
Wisal Alahdab, Global Biomedical Engineer at the International Committee of the Red Cross, shares insights into the risks for investors, and where meaningful impact can be made.
Healthcare innovation in the world's biggest markets
Wisal Alahdab, Global Biomedical Engineer at the International Committee of the Red Cross, shares insights into the risks for investors, and where meaningful impact can be made.
Syria’s healthcare system has been reshaped by war and collapse. Orthopaedic surgeon Dr Khaled Bitar, Head of Orthopaedic Surgery at Oriana Hospital, UAE, reflects on resilience and investment.
Khaled Bkeirati, Service Manager at Al-Faisaliah Medical Systems, outlines what international healthtech companies need to know before engaging with Syria.
Investors urged founders to understand local healthcare structures, insurance systems and patient segments, as well as articulate why their solution matters to the target market.
Sessions focused on how digital tools and health data are being used to support more preventative and responsive public health approaches.
The CARDIO4Cities programme builds on Brunei’s existing digital health platform, BruHealth, and seeks to use population-wide data and AI to identify high-risk individuals early.
The Chinese AI company is building a dedicated R&D and operations team in Nanning, with a focus on connecting to broader ASEAN markets.
Focus areas include healthy longevity, intelligent health systems for public policy, and large-scale use of digital, data and AI in healthcare.
The initiative is intended to promote collaboration in clinical treatment, research, standardisation, and the medical devices sector, with a focus on the regulated and safe use of digital technologies.